A leading pharmacist has warned Brits not to overlook changes to their skin – because they could be vital clues to a life-threatening condition. From a subtle discolouration to a change in texture or ...
Nipocalimab was well-tolerated over the six-month study period, with no major safety signals observed. The most common adverse events (AEs) were infections and infestations: 60.4% (n=32) in the ...
Daiichi Sankyo (TSE: 4568) will highlight new clinical research and real-world data from seven abstracts for TURALIO ® (pexidartinib) at the Connective Tissue Oncology Society (#CTOS2024) 2024 Annual ...
A new scientific statement from the American Heart Association highlights new clinical data related to diagnosis, risk classification and treatment, emphasizing the need for tailored management strate ...